In this issue:
Leukaemia selection
• Persistent CLL with maintained CMR after imatinib
• Rituximab in pregnancy
• Autoimmune cytopenia in CLL
Lymphoma selection
• Brentuximab vedotin in relapsed CD30+ lymphomas
• RICOVER-60: immunoblastic morphology predicts outcome
• BMI and outcomes in intermediate-grade B-cell non-Hodgkin lymphoma
• Treatment and prognosis of mature T-cell and NK-cell lymphoma
• Romidepsin in refractory cutaneous T-cell lymphoma
• HBV reactivation in DLBCL after rituximab combination
• Allogeneic transplantation in mycosis fungoides/Sézary syndrome
Please login below to download this issue (PDF)